The Shield Study

Study Objective:

• The study drug is a new potential treatment for a variety of diseases caused by the immune system malfunctioning. Known as autoimmune and/or autoinflammatory diseases. These conditions often cause a variety of adverse symptoms and conditions like rheumatoid arthritis and recurrent pericarditis.
• The goal of the study medication is to be an additional treatment option which is more easily administered compared to similar medications currently available.
• The study medication will be given as an injection under the skin, and participants will receive just one single dose.

Importance of Treatment:

• Developing treatments that can prevent the body's immune system from attacking itself (one way or another) is crucial for improving the lives of millions affected globally.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!